STOCKS51Job, U.S. Steel, Sorrento: 5 Top Stock Gainers ThursdayBy Rob LenihanSep 17, 2020 4:22 PM EDT
INVESTINGSorrento Gets FDA OK for Phase 1 Trial of Covid Antibody DrugBy Dan WeilSep 17, 2020 8:55 AM EDT
PRESS RELEASESSorrento Receives US FDA Clearance To Proceed With Phase 1 Clinical Trial Of STI-1499 (COVI-GUARD) Neutralizing Antibody In COVID-19 Positive PatientsBy GlobeNewswireSep 16, 2020 9:30 PM EDT
PRESS RELEASESSorrento Secures Exclusive License From Mayo Clinic For Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) PlatformBy GlobeNewswireSep 14, 2020 6:00 AM EDT
JIM CRAMERBuyers Are Back: Cramer's 'Mad Money' Recap (Wed. 9/9/20)By Scott RuttSep 9, 2020 8:55 PM EDT
PRESS RELEASESSorrento Announces The Closing Of Its Acquisition Of SmartPharm To Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient And In Vivo Production Of Antibody Therapeutics In PatientsBy GlobeNewswireSep 2, 2020 9:00 AM EDT
PRESS RELEASESSorrento Enters Into Merger Agreement To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 And Cancer TherapeuticsBy GlobeNewswireAug 20, 2020 4:05 PM EDT
PRESS RELEASESSorrento Announces FDA IND Filing Today For COVI-GUARD Neutralizing And High Potency Antibody Against SARS-CoV-2By GlobeNewswireAug 19, 2020 9:00 AM EDT
MARKETSTarget, Lowe's, Nvidia and Joe Biden - 5 Things You Must Know WednesdayBy Joseph WoelfelAug 19, 2020 7:55 AM EDT
PRESS RELEASESSorrento To Take Action Against Hindenburg Research For Statements Believed Intended To Manipulate Stock PriceBy GlobeNewswireAug 12, 2020 7:51 PM EDT
JIM CRAMERStupidly Bullish: Cramer's 'Mad Money' Recap (Tuesday 8/4/20)By Scott RuttAug 4, 2020 8:55 PM EDT
PRESS RELEASESSorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In SalivaBy PR NewswireJul 29, 2020 9:00 AM EDT
PRESS RELEASESSorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 And Cancer TherapeuticsBy PR NewswireJul 24, 2020 9:00 AM EDT
PRESS RELEASESDEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That A Class Action Lawsuit Has Been Filed Against Sorrento Therapeutics, Inc. And Encourages Investors To Contact The FirmBy Business WireJul 22, 2020 7:00 PM EDT
JIM CRAMERRoulette Market: Cramer's 'Mad Money' Recap (Monday 7/20/20)By Scott RuttJul 20, 2020 11:42 PM EDT
INVESTINGSorrento Shares Climb on FDA Covid-Drug Trial ClearanceBy Rob LenihanJul 20, 2020 3:21 PM EDT
PRESS RELEASESFDA Clears Abivertinib For Phase 2 Safety And Efficacy Study In Hospitalized Patients With Moderate To Severe COVID-19By PR NewswireJul 20, 2020 9:00 AM EDT
JIM CRAMERSore Thumb Index: Cramer's 'Mad Money' Recap (Tuesday 7/14/20)By Scott RuttJul 14, 2020 8:55 PM EDT
PRESS RELEASESSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Sorrento Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - SRNEBy PR NewswireJul 13, 2020 11:01 PM EDT
PRESS RELEASESThinking About Trading Options Or Stock In Sorrento Therapeutics, Netflix, United Airlines, Royal Caribbean Cruises, Or Plug Power?By PR NewswireJul 13, 2020 9:31 AM EDT
PRESS RELEASESSorrento Announces Selection Of T-VIVA-19™ As Targeted Protein Vaccine Candidate For SARS-CoV-2By GlobeNewswireJul 1, 2020 12:06 PM EDT
INVESTINGVaccine Maker ETF Climbs on Trump's Positive ProclamationBy Tony OwusuJun 25, 2020 12:52 PM EDT
PRESS RELEASESSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Sorrento Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - SRNEBy PR NewswireJun 24, 2020 6:07 PM EDT
PRESS RELEASESSRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders Of Class Action Against Sorrento Therapeutics, Inc. And Encourages Investors With Losses Exceeding 250K To Contact The FirmBy Business WireJun 24, 2020 11:00 AM EDT
